Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19
- PMID: 33045189
- PMCID: PMC7546712
- DOI: 10.1016/S0140-6736(20)32132-2
Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19
Comment on
-
Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17. N Engl J Med. 2021. PMID: 32678530 Free PMC article. Clinical Trial.
References
-
- Annane D, Renault A, Brun-Buisson C. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809–818. - PubMed
-
- Venkatesh B, Finfer S, Cohen J. Adjunctive glucocorticoids therapy in patients with septic shock. N Engl J Med. 2018;378:797–808. - PubMed
-
- Vilar J, Ferrando C, Martinez D. Dexamethasone treatment for ARDS: a multicentric randomized controlled trial. Lancet Respir Med. 2020;8:267–276. - PubMed
-
- Lamontagne F, Agoritsas T, Macdonald H. A living WHO guideline on drugs for COVID-19. BMJ. 2020;370 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical